West Pharma (WST) – Hot Guidance
-
West Pharma (WST) Tops Q1 EPS by 62c, Revenues Beat; Offers FY21 EPS/Revenues Guidance Above Consensus
-
West Pharma (WST) Tops Q4 EPS by 22c, Revenues Beat; Offers FY21 EPS/Revenue Guidance Above Consensus
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to WST Stock Lookup